Skip to main content

Are America's painkiller policies driving patients to heroin?

Are America's painkiller policies driving patients to heroin?


A group of government researchers say no, but others say it’s complicated

Share this story

Photo by Spencer Platt/Getty Images

Heroin use has spiked in the US, and some critics have charged that policy changes are to blame. Not so, say a group of government researchers, who exonerate the agencies they work for in a paper published yesterday. Outside drug use researchers find the paper’s claims debatable.

In the paper, published in the New England Journal of Medicine, researchers from the NIH, the CDC, and the Department of Health and Human Services1 discuss data that shows that heroin use started increasing in 2009 or earlier in various US locations — before governments implemented changes designed to curb painkiller misuse. These policies include stopping health care providers from dispensing painkillers from their offices in Florida, asking doctors in a number of states to check a patient database before writing a prescription, and developing prescription painkillers that are harder to crush. The government researchers argue instead that heroin's purity and its low cost were key factors in the recent increase in the drug's use.

The paper states that "the views expressed in this article are those of the authors and do not necessarily represent those of the National Institute on Drug Abuse, the National Institutes of Health, the Food and Drug Administration, the Centers for Disease Control and Prevention, or the Department of Health and Human Services."

Painkillers kill 46 people each day

Between 2002 and 2013, the rate of heroin-related overdose deaths almost quadrupled in the US. During almost the same time period, the rate of prescription painkillers misuse also quadrupled; as a result, the CDC estimates that prescription painkillers kill 46 people each day. That's why federal and state governments developed policies designed to reduce the risk of painkiller misuse. But some have suggested that these policies had some unintended consequences: when painkillers become hard to obtain, drug users may turn to heroin. And that's a worrisome thought because when heroin is injected, it can lead HIV or hepatitis C infections — in addition to overdoses. Now, scientists want to find out if prescription painkiller policies really did cause people to transition to heroin; that kind of information could help alter — or justify — the changes.

The authors of yesterday's paper "glossed over the negative aspects of these programs," says Ted Cicero, a neuropharmacologist at Washington University. Abuse deterrent drug formulations "are useful overall, but they are not the whole answer — and some users will as a result shift to other drugs including heroin."

The paper "glossed over the negative aspects of these programs."

Cicero also objects to the way one of his studies was interpreted by the authors of the paper. "They falsely conclude that we believe [abuse deterrent formulations] are not useful, and were solely responsible for the increase use of heroin," he told The Verge. This alone was not the only cause for the rapid rise in heroin across the country, "as we made clear" in the study.

Wilson Compton, deputy director of the National Institute on Drug Abuse and a co-author of the paper told The Verge in response that his team "thought that was what [Cicero] suggested in his earlier study, but it sounds like he and I agree that it's more complicated." Compton also says that what he thought "was crystal clear people have not always gotten right." Prescription painkiller use "is a risk factor for the transition to heroin, but the policies related to reducing the excess prescribing do not seem to be responsible for pushing the population toward heroin," he says.

"I'm skeptical."

Cicero wasn't the only expert to question the paper's conclusions. "I'm skeptical of the idea that heroin market forces alone are the cause leading to recent increases in heroin," says Pedro Mateu-Gelabert, a drug use researcher at New York University. It's conceivable that many people who developed painkiller dependency transitioned to heroin prior to the restrictions because heroin costs less, he says. But such a transition doesn't preclude the possibility that restriction polices could accelerate that transition for painkiller dependent individuals. "Both phenomena are not mutually exclusive."

For Joseph Palamar, a drug use researcher also at New York University, the policies are "a double-edged sword." Making it harder for people to obtain prescription painkillers for non-medical uses might prevent people from misusing the drugs, which would therefore reduce the chances of the individual moving onto heroin. But "cutting off the pill supply from someone addicted to opioid pills also increases the chances that he or she will move onto heroin, which is cheaper and more available."

In response, Compton told The Verge that he can't rule out the possibility that the policies "play any role in some individuals. "But the policies neither played a positive, nor particularly negative role in terms of the transition to heroin."

The policies didn't play a "negative role in terms of the transition to heroin."

Not everyone questions the paper's conclusions. "This paper is fascinating. I can't wait until it's out so I can send it to other people," Caleb Alexander, co-director of the Center for Drug Safety and Effectiveness at Johns Hopkins University, told The Verge before the paper was published. Although he appreciates people's concerns about potential unintended effects of these types of policies, he doesn't "feel like the policies underlie increases in heroin use."

There is some evidence to suggest that prescription painkiller policies have been successful at their intended goal. Between 2010 and 2012, the rate of painkiller prescribing stabilized in the US and even declined in some areas, the authors note. Still, it's clear that not everyone thinks the policies were harmless.

Besides driving an increase in heroin use, the policies may have had an effect on people who use painkillers for legitimate purposes, Cicero says — and that wasn't adequately discussed in the paper. Given that undertreated, chronic pain already affects over 116 million Americans, that's a troublesome thought. Veterans this year complained that the rules make it harder for them to get timely prescription renewals, which leaves them in pain. It's "worrisome [for] patient care if doctors are using them less because they are overly preoccupied with fear of abuse," Cicero says.

"We will probably never get policies 100 percent correct."

The importance of balancing availability of options for pain with the excess availability of painkillers due to overprescribing is mentioned in the paper, Compton says. He also states that no policy is perfect. "I'm a firm believer that we will probably never get policies 100 percent correct, and so we always need to pay attention to how to improve them." But Alexander says that the dilemma is a false one. "I'm not aware of any rigorous empirical evidence" that shows that the policies caused substantial barriers to legitimate painkiller use.

The debate over prescription painkiller policies won't end with this paper. It may take a lot more time to find out just how large (or how small) of an impact they've had on American drug use and American pain. Regardless, the US has an opioid misuse problem that doesn't seem to be going away. So for Mateu-Gelabert, the bottom line is that drug prevention efforts should go further. And expanding safe injection education and syringe access are "critical next steps in preventing the current spread of hepatitis C, and possibly HIV, among young opioid injectors."

Today’s Storystream

Feed refreshed Two hours ago Not just you

Thomas RickerTwo hours ago
Table breaks before Apple Watch Ultra’s sapphire glass.

”It’s the most rugged and capable Apple Watch yet,” said Apple at the launch of the Apple Watch Ultra (read The Verge review here). YouTuber TechRax put that claim to the test with a series of drop, scratch, and hammer tests. Takeaways: the titanium case will scratch with enough abuse, and that flat sapphire front crystal is tough — tougher than the table which cracks before the Ultra fails — but not indestructible.

Emma RothSep 25
Rihanna’s headlining the Super Bowl Halftime Show.

Apple Music’s set to sponsor the Halftime Show next February, and it’s starting out strong with a performance from Rihanna. I honestly can’t remember which company sponsored the Halftime Show before Pepsi, so it’ll be nice to see how Apple handles the show for Super Bowl LVII.

Emma RothSep 25
Starlink is growing.

The Elon Musk-owned satellite internet service, which covers all seven continents including Antarctica, has now made over 1 million user terminals. Musk has big plans for the service, which he hopes to expand to cruise ships, planes, and even school buses.

Musk recently said he’ll sidestep sanctions to activate the service in Iran, where the government put restrictions on communications due to mass protests. He followed through on his promise to bring Starlink to Ukraine at the start of Russia’s invasion, so we’ll have to wait and see if he manages to bring the service to Iran as well.

External Link
Emma RothSep 25
We might not get another Apple event this year.

While Apple was initially expected to hold an event to launch its rumored M2-equipped Macs and iPads in October, Bloomberg’s Mark Gurman predicts Apple will announce its new devices in a series of press releases, website updates, and media briefings instead.

I know that it probably takes a lot of work to put these polished events together, but if Apple does pass on it this year, I will kind of miss vibing to the livestream’s music and seeing all the new products get presented.

Welcome to the new Verge

Revolutionizing the media with blog posts

Nilay PatelSep 13
External Link
Emma RothSep 24
California Governor Gavin Newsom vetoes the state’s “BitLicense” law.

The bill, called the Digital Financial Assets Law, would establish a regulatory framework for companies that transact with cryptocurrency in the state, similar to New York’s BitLicense system. In a statement, Newsom says it’s “premature to lock a licensing structure” and that implementing such a program is a “costly undertaking:”

A more flexible approach is needed to ensure regulatory oversight can keep up with rapidly evolving technology and use cases, and is tailored with the proper tools to address trends and mitigate consumer harm.

Andrew WebsterSep 24
Look at this Thing.

At its Tudum event today, Netflix showed off a new clip from the Tim Burton series Wednesday, which focused on a very important character: the sentient hand known as Thing. The full series starts streaming on November 23rd.

The Verge
Andrew WebsterSep 24
Get ready for some Netflix news.

At 1PM ET today Netflix is streaming its second annual Tudum event, where you can expect to hear news about and see trailers from its biggest franchises, including The Witcher and Bridgerton. I’ll be covering the event live alongside my colleague Charles Pulliam-Moore, and you can also watch along at the link below. There will be lots of expected names during the stream, but I have my fingers crossed for a new season of Hemlock Grove.